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Abstract: The rare genus Ducrosia (Apiaceae family) consists of six species, which are mainly native 
to Asia, specifically to Iran and Iraq. The aerial parts of D. anethifolia, as the most common species, 
have been traditionally consumed to relieve headache, backache and colic pain, and have also been 
used as an anxiolytic, an antidepressant, and for treating insomnia. The antispasmodic and 
carminative effects of D. assadii, and the analgesic activity of D. flabellifolia, along with the insecticidal 
activities and use as a remedy of skin infections of D. ismaelis, have been previously documented. 
Among the 49 non-volatile secondary metabolites identified from D. anethifolia and D. ismaelis, 17 
linear furanocoumarins and 8 flavonoids have been characterized. The essential oil compositions of 
four species, including D. anethifolia, D. assadii, D. flabellifolia and D. ismaelis, have been analyzed, 
whereby aldehyde hydrocarbons, including decanal (10.1‒74.0%) and dodecanal (7.2‒33.41%), and 
α-pinene (4.0‒70.3%), were identified as the main aroma constituents. From the species of the genus, 
the bioactivities of D. anethifolia, as well as D. ismaelis, D. assadii and D. flabellifolia, have been 
previously investigated. Except one clinical trial, all the pharmacological data are derived from 
preclinical tests, predominantly focusing on antimicrobial, antioxidant, antiproliferative and 
cytotoxic activities in vitro, and neuroprotective, antidiabetic and analgesic effects in vivo. 
Considering the vast ethnobotanical uses of the plants in Iranian folk medicine, the phytochemical 
and pharmacological analysis of un-investigated species might be promising. Furthermore, due to 
extensive consumption of the Ducrosia genus, more scientific data are needed to support the safety 
and efficacy of these plants. 
Keywords: Ducrosia genus; folk medicine; phytoconstituents; non-volatile compounds; VOC; 
bioactivity 
 
1. Introduction 
The Apiaceae (syn. Umbelliferae) family, comprising 446 genera and 3820 species, is one of the 
largest plant families. The members of this family are mostly aromatic plants with hollow stems. The 
family is famed as the parsley, celery or carrot family. Most of the species have been used in cuisine as 
condiments and vegetables, and some of them have been consumed for medicinal purposes [1–3]. 
The genus Ducrosia (Apiaceae) consists of six species: D. ismaelis Asch., D. flabellifolia Boiss., D. 
assadii Alava., D. areysiana (Deflers) Pimenov & Kljuykov, D. inaccessa (C.C.Towns.) Pimenov & 
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Kljuykov and D. anethifolia (DC.) Boiss., which are mainly distributed in Africa and Asia, specifically 
in Iran, Afghanistan, Pakistan, Syria, Lebanon and Iraq [4–7]. 
D. anethifolia, as the most common plant in the genus and with local names “Moshgak”, 
“Roshgak” and “Moskbu” in Iran [8], is an herbaceous and biennial plant with a height of 10–30 cm. 
The stems are glabrous and branched with ramified and ovate-oblong leaves, with white florets in 
umbel inflorescence [9]. 
D. flabellifolia, possessing three lobed leaves with cuneate, flabelliform and flat segments, and 
yellow flowers [6] with the local name of “Al Haza”, grows as a rare species in volcanic cinders in the 
middle and north of Saudi Arabia [10–12], and in the deserts of eastern parts of Jordan [13]. 
D. assadii is an herbaceous and perennial plant (height 25–66 cm). The species has branched leaves 
and an umbel inflorescence with white flowers [14]. 
The documented ethnomedicinal application of Ducrosia species is limited to four species: D. 
anethifolia, D. assadii, D. flabellifolia and D. ismaelis (Table 1). D. anethifolia is known as the most popular 
plant in the genus. The aerial parts of D. anethifolia have been traditionally used to relieve headache, 
backache and colic pain in Asian countries, particularly Afghanistan, Iran, Iraq, Pakistan and Lebanon 
[4,15–21]. The effects of the aerial parts of D. anethifolia on the central nervous system were also 
reported, especially its use as anxiolytic, antidepressant and in treating insomnia [17,21–23]. For this 
plant, the following traditional applications have also been documented: treatment of cold [7,17,21,24], 
heartburn [21] and inflammation of the inner wall of the nose [7], and as an analgesic [4,17,18,20,25], a 
flavoring in food [4,23,26–30] and an insecticide [7,17,21,24]. The decoction prepared from aerial parts, 
leaves and seeds of D. anethifolia possesses carminative and lactiferous effects [31–34].  
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Table 1. The ethnobotanical application of Ducrosia species. 
Plant Species 
Plant 
Part 
Plant 
Preparation 
Ethnobotanical Uses Locality References 
D. anethifolia 
AP 
nd relieve for headache, backache, colic pains, catarrh 
Mountainous and flat areas in Africa, Iran, 
Afghanistan, Lebanon, Iraq, Pakistan 
[4,15–21] 
 treatment of inflammation of the inner wall of the nose 
Mountainous and flat areas in Africa, Iran, 
Afghanistan, Lebanon, Iraq, Pakistan 
[7] 
 
  
relaxation the mind and body, treatment of anxiety, 
depression, insomnia 
Iran (Shahrekord, Kashan), Arabian countries [17,21–23] 
 
 
analgesic 
 
Iran, Afghanistan, Pakistan, Syria, Lebanon, Saudi 
Arabia 
[4,17,18,20,25] 
 
treatment of cold 
 
Saudi Arabia 
Iran 
[24] 
[7,17,21] 
 
 relieve heartburn Iran [21] 
 use as animal feed 
Iran, Iraq, Pakistan, Afghanistan, Syria, Lebanon, 
and some of the Arabian countries 
[30] 
 
 use as flavoring agent in food 
Iran, Afghanistan, Pakistan, Syria, Lebanon, Saudi 
Arabia 
[4,23,26–30] 
 
use as insect and reptile repellent 
 
Saudi Arabia 
Iran 
[24] 
[7,17,21] 
AP, L, 
S 
decoction carminative, lactiferous agent nd [31–34] 
Se infusion relieve colic pain in children Afghanistan, Iran, Iraq, Pakistan [19] 
nd nd improve odor of foods and drinks 
Iran, Afghanistan, Pakistan, and the rest of Middle 
East 
[17] 
D. assadii 
AP 
 
nd 
 
analgesic, treatment of headache, backache, colic, colds, 
use as flavoring additive in foods 
Iran 
 
[29,35] 
nd nd 
flavoring additive in foods, antispasmodic, and 
carminative 
Iran (Kerman) [23,26] 
D. flabellifolia 
AP smoking treatment of toothache, general pain, sedative  Iran, Saudi Arabia, Jordan [13] 
L 
smoking 
 
treatment of catarrh, headache, backache, jaundice, relieve 
dental, general pains, sedative 
Iran, Iraq, Syria, Saudi Arabia, Jordan [36] 
D. ismaelis 
AP 
 
nd 
 
treatment of skin infections, use as insect and reptile 
repellents 
Africa and Iran, Iraq, Syria, Pakistan, Afghanistan, 
and Arabian countries 
[2,4,23,24,37] 
AP: aerial parts; L: leaf; nd: not determined; S: stem; Se: seed. 
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The aerial parts of D. assadii have been applied as an analgesic, a remedy for cold, because of 
their anti-inflammatory, antiseptic and soporific effects, and also as food additives in Iranian folk 
medicine [14,29,35]. In addition, the antispasmodic and carminative potentials of this species have 
been described in the Kerman province of Iran [23,26]. 
From ancient times, the aerial parts and leaves of D. flabellifolia have been smoked as a cigarette, 
since the local people in Iran, Jordan, Saudi Arabia, Iraq and Syria suppose that it can relieve various 
pains (e.g., backache, headache, toothache) [13,36]. 
Besides the aforementioned ethnomedicinal uses of the Ducrosia genus, the aerial parts of D. 
ismaelis have been used to treat skin infections, and as natural insecticides in some African and Asian 
countries [2,4,23,24,37]. 
The majority of pharmacological studies have been carried out with D. anethifolia. Except one 
clinical study, all the experiments have been carried out in preclinical (in vitro and in vivo) settings. 
Different plant products (isolated compounds, extracts and essential oils (EOs)) have been subjected 
to bioassays. The in vitro antimicrobial, antioxidant, antiproliferative and cytotoxic activities, along 
with the in vivo analgesic, anti-inflammatory and neuroprotective effects, are the most thoroughly 
evaluated bioactivities. 
Linear furanocoumarins have been previously identified as the major non-volatile components 
of the Ducrosia genus [2], whilst the main most volatile constituents were aliphatic hydrocarbons, 
with decanal (10.1–74.0%) [8,13,14,18,19,26,38–47] and dodecanal (7.2–33.41%) as the major 
constituents [8,13,14,19,26,39,41–43,45,46]. 
Considering the extensive use of Ducrosia species in traditional medicine, the number of studies 
dealing with this genus is increasing. The present review aims at comprehensively gathering the data 
on the genus regarding the traditional use, and phytochemical and pharmacological studies, of the 
Ducrosia genus for the first time. Databases including PubMed, Web of Science and SciFinder were 
used to search the reports using keyword “Ducrosia” (last search: 01.05.2020). 
2. Phytoconstituents 
2.1. Non-Volatile Components 
Only two species (D. anethifolia and D. ismaelis) have been subjected to preparative 
phytochemical experiments to identify their main non-volatile secondary metabolites. Overall, the 
characterized compounds comprise 17 linear furanocoumarins (1–17), 8 flavonoids (18–25) and 5 
terpenoids (26–30) as the major and characteristic constituents (Table 2). Furanocoumarins, as the 
major phytoconstituents of the studied species, were most abundant in chloroform extracts of the 
aerial parts, including stem, leaf and seed. The present flavonoids were identified in hydroalcoholic 
fractions of D. ismaelis’ aerial parts. Four compounds have been isolated as new secondary 
metabolites in the plant kingdom, including one dihydrochalcone glycoside, a new pterocarpan 
glycoside, one new monoterpene, and a novel sesquiterpene. The chemical structures of the identified 
non-volatile secondary metabolites are shown in Figure 1. 
Table 2. The non-volatile phytoconstituents identified from Ducrosia species. 
No. Compound Classification 
Ducrosia 
Species 
Plant Part 
Plant 
Extract 
Fraction 
Refere
nce 
1 Psoralen  L.F D. anethifolia L and S EtOAc [48] 
2 5-Methoxypsoralen (syn. bergapten) L.F D. anethifolia L and S EtOAc [48] 
3 Oxypeucedanin L.F D. anethifolia AP CHCl3 [2] 
4 Oxypeucedanin methanolate L.F D. anethifolia 
AP CHCl3 [2] 
L and S EtOAc [48] 
5 8-Ethoxypsoralen L.F D. anethifolia AP EtOAc [49] 
6 Isogospherol L.F D. anethifolia AP CHCl3 [2] 
7 Isooxypeucedanin L.F D. anethifolia L and S EtOAc [48] 
8 8-Methoxypsoralen (syn. xanthotoxin) L.F D. anethifolia L and S EtOAc [48] 
9 Heraclenin L.F D. anethifolia AP CHCl3 [2] 
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Se DCM [50] 
10 Prangenin (syn. oxyimperatorin) L.F D. anethifolia AP EtOAc [49] 
11 Heraclenol L.F D. anethifolia 
AP CHCl3 [2] 
Se DCM [50] 
12 Imperatorin  L.F D. anethifolia 
AP CHCl3 [2] 
L and S EtOAc [48] 
13 Oxypeucedanin ethanolate  L.F D. ismaelis AP CHCl3 [51] 
14 
(+)-Oxypeucedanin hydrate (syn. 
aviprin) 
L.F 
D. anethifolia 
L and S EtOAc [48] 
AP CHCl3 [2] 
Se DCM [50] 
D. ismaelis AP CHCl3 [51] 
15 
(‒)-Oxypeucedanin hydrate (syn. 
prangol) 
L.F D. anethifolia AP CHCl3 [2]  
16 Pabulenol (syn. pangelin) 
L.F 
D. anethifolia 
AP CHCl3 [2,52] 
 L and S EtOAc [48] 
17 Saxalin L.F D. ismaelis AP CHCl3 [51] 
18 Quercetin 3-glucoside flavonol D. ismaelis L and S EtOH (70%) [53] 
19 Quercetin 3-polyglycoside flavonol D. ismaelis L and S EtOH (70%) [53] 
20 Daidzin isoflavone D. ismaelis AP Aqueous [54] 
21 Genistin isoflavone D. ismaelis AP Aqueous [54] 
22 Daidzein-4′-O-β-D-glucopyranoside isoflavone D. ismaelis AP Aqueous [54] 
23 Prunetrin isoflavone D. ismaelis AP Aqueous [54] 
24 Isobavachalcone chalcone  D. ismaelis AP Aqueous [54] 
25 Ismaeloside A chalcone D. ismaelis AP Aqueous [54] 
26 Ducrosin A  terpene  D. anethifolia Se DCM [50] 
27 8-O-Debenzoylpaeoniflorin terpene D. anethifolia AP CHCl3 [52] 
28 Ducrosin B terpene D. anethifolia Se DCM [50] 
29 Isoaromadendrene epoxide terpene D. anethifolia AP EtOAc [49] 
30 Aromadendrene oxide terpene D. anethifolia AP EtOAc [49] 
31 Pseudosolasodine diacetate alkaloid D. anethifolia AP EtOAc [49] 
32 Harmine alkaloid D. anethifolia AP CHCl3 [2] 
33 
4′-Hydroxy-3,3′,4,5,5′- pentamethoxy-
7,9′:7′,9-diepoxylignane 
lignan D. ismaelis AP Aqueous [54] 
34 Liriodendrin lignan D. ismaelis AP Aqueous [54] 
35 Pinoresinol-4′-O-β-D-glucopyranoside lignan D. ismaelis AP Aqueous [54] 
36 Stigmasterol phytosterol D. anethifolia Se DCM [50] 
37 3-O-glucopyranosyl-β-sitosterol phytosterol D. anethifolia L and S EtOAc [48] 
38 Ursodeoxycholic acid phytosterol D. anethifolia AP EtOAc [49] 
39 Citrusin C Ph.G D. ismaelis AP Aqueous [54] 
40 Coniferin Ph.G D. ismaelis AP Aqueous [54] 
41 Glycinol-3-O-β-D-glucopyranoside P.G D. ismaelis AP Aqueous [54] 
42 Coumestrol phytoestrogen D. ismaelis AP Aqueous [54] 
43 Vanillic aldehyde P.A D. anethifolia AP CHCl3 [2] 
44 (Z)-Plicatin B phenolic acid D. ismaelis AP Aqueous [54] 
45 3-Hydroxy-α-ionone  A.M D. anethifolia AP CHCl3 [2] 
46 Blumenol-C-glucoside F.A D. ismaelis AP Aqueous [54] 
47 2-C-Methyl-erythrytol A.A D. anethifolia AP CHCl3 [2] 
48 Succinic anhydride C.D.A D. anethifolia AP EtOAc [49] 
49 Deoxyspergualin amide D. anethifolia AP EtOAc [49] 
AP: aerial part; CHCl3: chloroform; DCM: dichloromethane; EtOAc: ethyl acetate; L: leaf; S: stem; Se: 
seed; Ph.G: phenolic glycoside; P.G: pterocarpan glycoside; P.A: phenolic aldehyde; L.F: linear 
furanocoumarin; A.M: apocarotenoid monoterpenoid; F.A: fatty acid; A.A: aliphatic alcohol; C.D.A: 
cyclic dicarboxylic anhydride. 
2.1.1. Furanocoumarins 
Coumarin derivatives are considered the most characteristic phytoconstituents of the Apiaceae 
family [55–57]. The aerial parts of D. anethifolia collected in Saudi Arabia have been examined so as 
to isolate and identify its major compounds. Psoralen (1) was isolated from the ethyl acetate extract 
of the leaf and stem of D. anethifolia, together with 5-methoxypsoralen (syn. bergapten) (2), 
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oxypeucedanin methanolate (4), isooxypeucedanin (7), 8-methoxypsoralen (syn. xanthotoxin) (8), 
imperatorin (12), oxypeucedanin hydrate (14) and pabulenol (syn. pangelin) (16) [48]. 
From the ethyl acetate extract of the fresh aerial parts of D. anethifolia harvested from Saudi 
Arabia, 8-ethoxypsoralen (5) and prangenin (syn. oxyimperatorin) (10) have been identified by GC-
MS as the predominant compounds (6.5% and 6.26%, respectively) [49]. 
In a former study performed by our group, nine linear furanocoumarins were isolated from a 
chloroform extract obtained from D. anethifolia’s aerial parts, harvested from Iran. Oxypeucedanin 
(3), oxypeucedanin methanolate (4), isogospherol (6), heraclenin (9), heraclenol (11), imperatorin (12) 
and pabulenol (16) were isolated as the major compounds; in addition, by analysis of optical 
rotations, two isolated diastereomers of (+)-oxypeucedanin hydrate (syn. aviprin) (14) and (‒)-
oxypeucedanin hydrate (syn. prangol) (15) were identified [2]. Moreover, heraclenin (9), heraclenol 
(11) and oxypeucedanin hydrate (14) have been isolated from a dichloromethane extract of D. 
anethifolia seeds [50]. 
Stavri et al. (2003) isolated pangelin (syn. pabulenol) (16) from the chloroform extract of D. 
anethifolia’s aerial parts, grown in Kuwait [52].  
D. ismaelis has also been analyzed in order to identify its non-volatile secondary metabolites. 
Three furanocoumarins, namely oxypeucedanin ethanolate (13), oxypeucedanin hydrate (14) and 
saxalin (17), were isolated from the chloroform extract of the aerial parts [51]. 
2.1.2. Flavonoids 
Flavonoids have only been identified in D. ismaelis. Two glycosylated quercetin derivatives, 
quercetin-3-glucoside (18) and quercetin-3-polyglycoside (19), were isolated from the hydroethanolic 
extracts of the leaves and stems of this species [53]. 
From the aqueous extract of D. ismaelis’ aerial parts, four isoflavone glycosides, including 
daidzin (20), genistin (21), daidzein-4′-O-β-D-glucopyranoside (22) and prunetrin (23), have been 
isolated. Moreover, two chalcones, including a new compound ismaeloside A (25) and 
isobavachalcone (24), have been isolated [54]. 
2.1.3. Terpenoids 
All the five identified terpenoids in the Ducrosia genus have been reportedly extracted from the 
seeds and aerial parts of D. anethifolia. From the dichloromethane extract of the seeds, the new 
monoterpene and sesquiterpene compounds ducrosin A (26) and ducrosin B (28) were isolated, 
respectively [50]. A monoterpene glycoside, 8-O-debenzoylpaeoniflorin (27), has been isolated from 
the chloroform extract of the aerial parts [52]. Furthermore, by applying GC-MS, two oxygenated 
sesquiterpenes, isoaromadendrene epoxide (29) and aromadendrene oxide (30), have been identified 
as the major components from the ethyl acetate extract of aerial parts (7.49% and 2.94%, respectively) 
[49]. 
2.1.4. Alkaloids 
So far, two alkaloids have been identified in the aerial parts of D. anethifolia. The GC-MS analysis 
of the ethyl acetate extract of D. anethifolia resulted in the identification of pseudosolasodine diacetate 
(31) (1.5%) [49], whereas its chloroform extract contained a well-known alkaloid, harmine (32) [2]. 
2.1.5. Lignans 
By using various chromatographic techniques, two lignan glycosides, along with an aglycon, 
have been isolated from D. ismaelis. The aqueous extract of its aerial parts has allowed the isolation 
of 4′-hydroxy-3,3′,4,5,5′-pentamethoxy-7,9′:7′,9-diepoxylignane (33) as aglycone, as well as 
glycosylated lignans, namely liriodendrin (34) and pinoresinol-4′-O-β-D-glucopyranoside (35) [54]. 
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2.1.6. Phytosterols 
Stigmasterol (36) was isolated from the dichloromethane extract of D. anethifolia seeds [50], while 
3-O-glucopyranosyl-β-sitosterol (37) was extracted from the ethyl acetate extract of the leaf and stem 
samples [49]. Ursodeoxycholic acid (38) as a sterol derivative (1.39%) was identified in the ethyl 
acetate extract of D. anethifolia’s aerial parts [49]. 
2.1.7. Miscellaneous Compounds 
Two phenolic glycosides (citrusin C (39) and coniferin (40)), beside the pterocarpan glycoside 
glycinol-3-O-β-D-glucopyranoside (41) as a novel phytoalexin, were isolated from the aqueous extract 
of D. ismaelis’ aerial parts [54]. Vanillic aldehyde (43), 3-hydroxy-α-ionone (45) and 2-C-methyl-
erythrytol (47) were isolated from D. anethifolia’s aerial parts (chloroform extract) [2]. 
Morgan et al. (2014) analyzed the aqueous fractions of D. ismaelis’ aerial part extracts, and 
isolated blumenol-C-glucoside (46), the phytoestrogen coumestrol (42) and the hydroxycinnamic acid 
derivative (Z)-plicatin B (44) [54]. Succinic anhydride (48) and deoxyspergualin (49) were further 
specified as the predominant phytoconstituents of D. anethifolia’s aerial parts (3.37% and 2.08%, 
respectively) [49]. 2.2. Volatile Components 
The essential oil (EO) compositions of different plant parts (aerial part, fruit, flower, leaf and 
stem) of D. anethifolia, D. assadii, D. flabellifolia and D. ismaelis, collected from Iran, Saudi Arabia and 
Jordan, have been analyzed (Table 3). 
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Figure 1. Chemical structures of the non-volatile phytochemicals identified from Ducrosia species. 
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Table 3. Volatile compositions characterized in Ducrosia species. 
Ducrosia 
Species 
Origin 
Analyzed Plant 
Part 
Stage/month of 
Sample Harvesting 
Extraction 
Method 
Yield (%) Major Compounds and Chemical Classes (%) References 
D. anethifolia 
Saudi Arabia (Riyadh 
province) 
Fresh AP nd HD nd 
decanal (28.90), chrysanthenyl acetate (10.04), 
dodecanal (8.09) 
 
C.C:  
aldehyde hydrocarbons (39.21), oxygenated 
monoterpenes (14.49), monoterpenes hydrocarbons 
(11.60) 
[43] 
Iran (Sistan and 
Balouchestan) 
Dried AP U.S/May 2015 HD nd 
chrysanthenyl acetate (41.54), decanal (19.55), 
methyl chavicol (9.25) 
[44] 
Iran AP nd HD nd 
cis-chrysanthenyl acetate (72.28), β-eudesmol (8.79), 
E-anethole (4.33) 
[58] 
Iran (Bushehr) Dried AP nd HD nd 
cis-chrysanthenyl acetate (72.28), 1,8-cineole (14.12), 
β-eudesmol (8.79) 
[59] 
Iran (Kerman province) Fresh AP nd HD nd 
N-decanal (70.1), α-pinene (12.40), β-caryophyllene 
(0.90) 
[18] 
Iran (Karaj) 
Fresh AP (L, S and 
Fr) 
L and S: May-June 
I979 
Fr: July I979 
HD 2 (v/w) α-pinene (59.2), N-decanal (52.2), N-dodecanal (20.5) [19] 
Iran (Fars province) 
Dried AP (S, L and 
Fl) 
 
Fl.S/April 2015 HD 
Kazeroun P: 0.43 ± 
0.02 (w/w) 
Noorabad P: 0.23 ± 
0.09 (w/w) 
Shiraz P-1: 0.15 ± 
0.02 (w/w) 
Shiraz P-2: 0.64 ± 
0.02 (w/w) 
Firoozabad P: 0.2 ± 
0.03 (w/w) 
Farashband P: 0.45 
± 0.16 (w/w) 
Jahrom P-1: 0.55 ± 
0.08 (w/w) 
Jahrom P-2: 0.93 ± 
0.04 (w/w) 
N-decanal (35.85), dodecanal (34.06), α-pinene (8.20) 
N-decanal (29.44), dodecanal (21.83), (2e)-dodecenal 
(16.86) 
N-decanal (44.86), dodecanal (11.56), (2e)-dodecenal 
(5.74) 
N-decanal (18.81), dodecanal (16.64), decanoic acid 
(12.63) 
N-decanal (34.74), dodecanal (11.69), limonene (1.49) 
N-decanal (43.96), dodecanal (19.26), α-pinene (8.30) 
α-pinene (6.93), cis-chrysanthenyl acetate (6.73), N-
decanol (5.63) 
N-decanol (49.22), α-pinene (16.54), undecanal (4.81) 
N-decanal (41.49), dodecanal (18.58), α-pinene (6.27) 
N-decanal (24.58), α-pinene (14.17), dodecanal 
(11.69)  
[45] 
Pharmaceuticals 2020, 13, 175 11 of 23 
 
Ghir P: 0.27 ± 0.14 
(w/w) 
Darab P: 0.17 ± 0.03 
(w/w) 
Iran (Tehran, 
Damavand) 
L Fl.S/June 2011 
HD 
SD 
SFE 
0.53 (w/w) 
0.89 (w/w) 
1.7 (w/w) 
N-decanal (30.31), dodecenal (14.35), N-decanol 
(11.04) 
N-decanal (27.64), dodecanal (15.26), N-decanol 
(14.06) 
N-decanal (25.67), dodecanal (17.25), dodecenal 
(16.23) 
[46] 
Iran (Kerman, Mehdi 
Abad) 
Dried AP Fl.S/June 2006 HD nd decanal (54.0), α-pinene (11.6), terpinolene (3.2) [47] 
Iran (Fars, Neyriz) Dried L Fl.S/May 2012 HD nd α-pinene (70.3), β-myrcene (6.9), β-pinene (6.3) [15] 
Iran (Fars, Larestan) Dried AP Fl.S HD 0.35 (w/w) decanal (18.8), α-thujene (14.5), decanol (9.3) [38] 
Iran (West and 
Southwest) 
Dried AP Spring 2008 HD nd 
dodecanal (28.8), decanal (21.1), (E)-2-tridecen-1-al 
(15.8) 
[8] 
D. assadii 
Iran (Kerman, 
Dehbakri) 
Dried flowering 
and fruiting AP 
Fl.S/June 2011 
Fr.S/August 2011 
 
 
Fl.S/June 2011 
Fr.S/August 2011 
SD nd 
N-decanal (46.68), N-decanol (13.79), dodecanal 
(10.01)  
N-decanal (42.21),N-decanol (13.27), dodecanal 
(8.87) 
 
C.C: 
aliphatic (78.15), oxygenated aliphatic (76.88), 
monoterpenes (17.49) 
aliphatic (77.71), oxygenated aliphatic (77.25), 
monoterpenes (14.76) 
[26] 
Iran (Kerman, Lalehzar 
and Dehbakri) 
Dried AP Fl.S/July 2007 C.S-HD nd 
Lalehzar 1: decanal (74.0), dodecanal (7.2), α-pinene 
(4.0) 
Lalehzar 2: decanal (35.2), nonadecane (12), 
citronellyl acetate (11.6) 
Dehbakrii: decanal (36.4), dodecanal (8.1), cis-
chrysanthenyl acetate (6.7) 
[14] 
Iran (Kerman, Bakrii) Dried AP Fl.S/July 2002 HD nd 
decanal (36.4), dodecanal (8.1), cis-chrysanthenyl 
acetate (6.7) 
[39] 
Iran (Kerman, 
Dehbakri) 
Fresh AP 
fresh Fr 
May and September 
2007 
HD 
AP: 0.2 (v/w) 
Fr: 1.1 (v/w) 
α-pinene (14.5), decanal (10.1), decanoic acid (10.4) 
verbenol + myrtenal (71.0), allo-ocimene + δ-3-
carene (4.0), crysanthenyl acetate (3.3) 
[40] 
D. flabellifolia 
Jordan (Northwest of 
the Nature Reserve 
Azraq) 
Fresh L 
Dry L 
Fresh Fl 
Summer 2012 
HD 
 
 
nd 
N-decanal (36.61), N-decanol (15.20), dodecanal 
(7.50) 
[13] 
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Dry Fl 
 
Fresh L 
Dry L 
Fresh Fl 
Dry Fl 
 
 
SPME 
N-decanal (21.00), dodecanal (8.29), N-β-nonane 
(7.06) 
nd 
nd  
 
N-decanal (24.44), α-pinene (15.72), (2Z)-octane 
(7.04) 
N-decanol (27.88), β-pinene (13.56), terpinolene 
(10.51) 
dodecanal (33.41), N-decanal (14.41), n-decanol 
(11.49) 
nd 
Iran (west and 
southwest) 
Dried AP Spring 2008 HD nd decanal (32.8), dodecanal (32.6), decanol (4.3) [8] 
Saudi Arabia (northern 
border) 
S 
L 
Fl 
 
 
S 
 
L 
 
Fl 
nd HD nd 
decanal (38.18), dodecanal (20.62), tetradecanal 
(6.31) 
decanal (50.02), dodecanal (14.82), α-pinene (4.36) 
decanal (47.92), dodecanal (18.54), N-decanol (4.34) 
 
C.C:  
aldehyde hydrocarbons (65.11), oxygenated 
sesquiterpenes (10.83), monoterpenes hydrocarbons 
(2.48) 
aldehyde hydrocarbons (65.39), monoterpenes 
hydrocarbons (9.37), oxygenated monoterpenes 
(3.35) 
aldehyde hydrocarbons (67.30), monoterpenes 
hydrocarbons (5.53), oxygenated monoterpenes 
(5.15) 
[41] 
D. ismaelis Saudi Arabia (Riyadh) Dried AP January 2016 HD nd 
decanal (40.6), α-pinene (15.1), dodecanal (13.7) 
C.C: oxygenated monoterpenes (51.6) 
[42] 
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Most of the studies were carried out on D. anethifolia harvested from Iran. Overall, the highest 
EO yield in the genus was observed in fresh aerial parts (2% (v/w) [19], while the lowest content was 
reported in the dried aerial parts of the same species (0.15% (w/w) [45]. Although the EOs have been 
mostly extracted by hydro-distillation (HD), steam distillation (SD), supercritical fluid (SFE) and solid 
phase micro extraction (SPME) were also applied. In a comparison study, the leaves of D. anethifolia 
were extracted by three methods, and it was observed that the highest yield could be obtained by 
SFE (1.7% (w/w), compared to HD and SD (0.53% and 0.89% (w/w), respectively) [46].  
In general, aldehyde hydrocarbons, including decanal and dodecanal, were identified as the 
main aromatic compounds in the Ducrosia species. The highest content of decanal was reported in 
the aerial parts of D. assadii harvested from Lalehzar, Iran (74.0%) [14], whereas the EO from the aerial 
parts of the same plant collected from Dehbakri, Iran, contained only 10.1% [40]. Dodecanal was 
found in almost all the studied species, and it is the second major EO compound, with the highest 
amount detected in the fresh flowers of the EO of a Jordanian D. flabellifolia sample (33.41%) [13]. cis-
Chrysanthenyl acetate (3.2‒72.28%) was characterized in D. anethifolia [43‒45,47,58,59] and D. assadii 
[14,39,40]; furthermore, α-pinene as a monoterpene hydrocarbon was identified in all the species, 
with highest and lowest amounts in the leaves of D. anethifolia (70.3%) [15] and D. assadii’s aerial parts 
(4.0%), respectively [14]. The chemical structures of the main volatile compounds of the Ducrosia 
genus are displayed in Figure 2. 
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Figure 2. Chemical structures of the major essential oil compounds identified in the Ducrosia genus. 
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3. Pharmacological Activities 
The crude extracts, EOs and isolated phytoconstituents of the Ducrosia species have been 
subjected to diverse in vitro and in vivo bioactivity assays. The most thoroughly studied species was 
D. anethifolia [2,8,15,18‒20,48‒51,58‒68], however other species, such as D. ismaelis [42,52,60], D. assadii 
[26] and D. flabellifolia [8,61], have also been tested. 
In one clinical trial performed on 90 patients, the anti-anxiety effect of a D. anethifolia EO-
containing capsule with 50 mg of plant material was assessed in patients after acute myocardial 
infarction. Using the State-Trait Anxiety Inventory (STAI), the anti-anxiety effect was reported 96 h 
after taking the medication orally (twice a day), with a mean score of 33.35 ± 6.23 in the intervention 
group, while the anxiety rate was 36.48 ± 5.33 in the control group [62]. This is the only clinical trial 
carried out with Ducrosia-based products. 
The antiradical, antimicrobial, antiproliferative and cytotoxic effects were the most extensively 
assessed bioactivities. In vivo studies mainly analyzed D. anethifolia EO for its analgesic, anti-anxiety, 
sedative, anti-inflammatory, immunostimulatory and neuroprotective activities, EO and extract for 
their anticonvulsant effect, extracts and isolated compounds for their antidiabetic potential, and 
extracts for their effects on testosterone hormone level. The anti-osteoporotic activity of isolated 
compounds from D. ismaelis has also been reported. 
In the in vitro experiments, EO, extracts and isolated compounds of D. anethifolia exhibited 
antimicrobial, antioxidant, antiproliferative, cytotoxic and antidiabetic effects. The antioxidant 
activities of D. ismaelis (EO and isolated compounds), D. assadii (EO) and D. flabellifolia (EO and 
extract), besides the antimicrobial effects of EO and extracts from D. ismaelis, have also been reported 
(Table S1 (Supplementary materials)). 
3.1. Analgesic Activity 
The in vivo analgesic activity of EO extracted from D. anethifolia leaves has been evaluated in 84 
male mice. Dose-dependent effects were observed using three assays, where the plant samples at 300 
mg/kg had the highest potency, compared to 30 and 100 mg/kg, in the delayed response of mouse 
tail-flick (5.8 /s), writhing (15 number) and pain scores in acute (0.8 score) and chronic phases (0.7 
score), assessed by tail-flick, writhing and formalin methods, compared to morphine (1 mg/kg). The 
abovementioned parameters of 8.0 /s, 2.5 number and 0.5 and 0.4 scores, respectively, were applied 
as positive control [63]. 
3.2. Anti-Anxiety and Sedative 
The EO of D. anethifolia’s aerial parts was tested in the elevated plus maze test on mice. The 
percentage of time spent in the open arms within 5 min of administration to the animals was 
investigated. 
The time spent in the open arm was 29% at 25 and 50 mg/kg doses of the EOs, while at 400 
mg/kg, the percentage of entries into the open arms was 22%, and the efficacy was inferior to 
diazepam at 3 mg/kg, with 30% and 22%, respectively [18]. 
In this study, the response of spontaneous locomotor activity to the various EOs doses was also 
analyzed, during a 15 min period at 5 min of intervals. The treatments with 200 and 400 mg/kg of Eos 
both resulted in lower activity in the animals, compared to diazepam (3 mg/kg) [18]. 
3.3. Anticonvulsant Activity 
The hydro-ethanolic extract (20%) from D. anethifolia’s aerial parts was assayed for its 
anticonvulsant effect on Wistar rats after inducing seizures by pentylenetetrazol (80 mg/kg). The 
plant extract at 2 mg/kg shortened the total length of seizure, which was 148.75 s, whilst its effect was 
inferior to diazepam (1 mg/kg), with a 19.37 s seizure [64]. 
In a similar study, the anticonvulsant effects of EO obtained from the aerial parts, and α-pinene 
as the major volatile component, of D. anethifolia were tested on Wistar rats suffering 
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pentylenetetrazol (80 mg/kg)-induced seizures. The highest protection (100%) was recorded after the 
administration of 50 mg/kg EO, whereas diazepam showed complete protection (100%) at 2 mg/kg. 
The duration of the tonic seizure was the lowest with the application of 0.4 mg/kg of α-pinene, at 8 s, 
compared to EOs at doses of 25, 50, 100 and 200 mg/kg, while diazepam (2 mg/kg) was more active, 
with 4 s seizures [65]. 
3.4. Antidiabetic Activity 
In a previous comprehensive study, the antidiabetic potency of D. anethifolia samples was 
evaluated in both in vitro and in vivo, and the results demonstrated promising activity. Among the 
leaf and stem extracts, and the isolated furanocoumarins, which were applied in concentrations of 
10–100 µg/mL, imperatorin (12) and the crude extract showed the most potent inhibition of  -amylase 
and  -glucosidase enzymes. Imperatorin (12) inhibited the enzyme  -amylase with an effect (52.26% 
at 500 µg/mL) similar to that of the positive control, acarbose (52.55% at 500 µg/mL). The extract and 
imperatorin (12) inhibited  -glucosidase enzyme activity at a concentration of 10 µg/mL, with 
inhibition of 28.89%, compared to acarbose (at 10 µg/mL) with 29.94% [48]. 
In a further study, albino rats with streptozotocin-induced diabetes were treated for 45 days with 
500 mg/kg hydro-ethanolic extract (80%), obtained from D. anethifolia leaf and stem. In comparison 
to the glibenclamide group at 5 mg/kg, with a blood glucose level of 151.50 mg/dL, the plant extract 
showed a good effect in decreasing the blood glucose level, with the level measured at 165.60 mg/dL 
[48]. 
3.5. Anti-Inflammatory Activity 
Measured using a xylene-induced ear edema assay, the EO from D. anethifolia’s aerial parts (100 
mg/kg) exhibited anti-inflammatory effects on mice with efficacy similar to dexamethasone (15 
mg/kg), as determined by their reducing of the ear edema to values of 3.8% and 3.2%, respectively, 
compared to the control group [63]. 
3.6. Antimicrobial Activities 
EOs, extracts and pure compounds of D. anethifolia, and the EOs and extracts of D. ismaelis’ aerial 
parts have been investigated for antimicrobial activities. 
Habibi et al. (2017) studied the EO of the aerial parts of D. anethifolia to evaluate its efficacy 
against some food-borne pathogens. The highest inhibitory effect was recorded against Bacillus cereus, 
by disk diffusion (DD) and microbroth dilution (MbD) assays, with an inhibition zone (IZ) of 13.33 
mm, a minimum inhibitory concentration (MIC) of 7.81 mg/mL, and a minimum bactericidal 
concentration (MBC) of 31.25 mg/mL. These activities were comparable to tetracycline being used as 
the antibacterial drug, which possessed an IZ of 18 mm, an MIC of 7.81 mg/mL, and an MBC of 15.62 
mg/mL [58]. 
In another study, the EO obtained from D. anethifolia’s aerial parts exhibited a moderate potency 
against the Gram-negative bacterium Proteus vulgaris, experimented via DD (IZ: 26.6 mm) and MbD 
(MIC: 0.39 mg/mL, MBC: 1.56 mg/mL), however it was less effective than tetracycline as the positive 
control (IZ: 32.6 mm, MIC: 0.19 mg/mL, MBC: 0.39 mg/mL) [59]. 
By applying a DD assay, the hydro-methanolic extract (90%) from the aerial parts of D. 
anethifolia, in different concentrations (0.5–4 mg/disk), was analyzed to assess its antimicrobial 
activities against two Gram-positive (B. subtilis, Staphylococcus aureus), two Gram-negative 
(Escherichia coli, Pseudomonas aeruginosa) bacteria, and one pathogenic yeast (Candida albicans). The 
extract at a concentration of 4 mg/disk possessed antimicrobial effects with an IZ of 10.7 mm against 
E. coli, while gentamicin (10 µg/disk) was more active, with a 15 mm inhibitory zone. Furthermore, 
against C. albicans, the extract in concentrations of 0.5‒2 mg/disk and 4 mg/disk showed activities 
with 6.4 and 6.7 mm, respectively, compared to ketoconazole (10 µg/disk), which had a 10 mm 
inhibition zone [66]. 
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Two assays of MbD and DD were utilized to investigate the antibacterial potential of D. 
anethifolia EO and decanal, as its main component, against clinically isolated methicillin-resistant and 
methicillin-susceptible S. aureus. Overall, the EO was the stronger agent in inhibiting the bacteria, 
compared to the decanal. The EO had inhibition zones of 10.6 and 24.86 mm and minimum inhibition 
concentrations of 31.25 and 62.5 µg/mL, assessed by DD and MbD methods, respectively. The EO 
also had a good synergistic effect with methicillin [20]. 
Pangelin (syn. pabulenol) (16), a prenylated furanocoumarin isolated from D. anethifolia, 
exhibited weak anti-mycobacterial activity, with MIC values of 128 µg/mL against Mycobacterium 
fortuitum and 64 µg/mL against M. smegmatis, M. phlei and M. aurum. Ethambutol and isoniazid, on 
the other hand, were more potent as positive controls, with MICs of 0.25–8 µg/mL, and 0.5–2 µg/mL, 
respectively, evaluated by MbD assay [52]. 
The antimicrobial potency of EO extracted from the herb and fruits of D. anethifolia, along with 
its main oxygen-containing aliphatic constituents (N-decanal, N-dodecanal, N-decanol, N-dodecanol 
and trans-2-dodecenal), using a DD assay against several Gram-positive and Gram-negative bacteria, 
yeast and fungi strains, was tested. No inhibitory effect was detected against the two Gram-negative 
bacteria P. aeruginosa and E. coli; nevertheless, several samples demonstrated high activities. These 
included the EO of the herb against Trichophyton rubrum and Epidermophyton floccosum (IZ: 88 mm), 
and trans-2-dodecenal against T. rubrum (IZ: 86 mm) compared to griseofulvin (50 mg/mL, IZ: 26 
mm, 32 mm, respectively); also n-decanal, n-decanol (IZ: 88 mm) and n-dodecanal (IZ: 94 mm) against 
C. albicans, compared to nystatin (50 mg/mL, IZ: 13 mm) [19]. 
In an in vivo study, the aqueous extract of D. ismaelis was orally administered to female albino 
mice. The mycotoxin-producing liquid culture of Aspergillus flavus (50 mL) was administered instead 
of water to a group of animals. Low fungal contamination, with total fungi counts of 250 colony-
forming unit/g, was observed in the animals treated with the plant extract [60]. The EO yielded by 
the aerial parts of D. ismaelis was subjected to MbD assay to evaluate its antimicrobial effect. The 
remarkable effects of the EO were reported, particularly against the Gram-positive bacteria S. aureus 
and S. epidermidis, with MIC and MBC values of 0.07 and 0.15 mg/mL, compared to gentamycin (MIC 
and MBC values of 7.8 and 15.6 mg/mL, respectively). Moreover, the EO showed good inhibitory 
activity against C. albicans and Rhodotorula sp., with the minimum fungicidal concentration (MFC) 
0.62 mg/mL, and against fungi Aspergillus ochraceus and Penicillium chrysogenum (MFC: 0.31 mg/mL), 
while the positive control nystatin was less potent, with an MFC value of 7.0 mg/mL [42]. 
3.7. Anti-Osteoporotic Activity 
The in vitro anti-osteoporotic activities of some secondary metabolites of D. ismaelis were 
determined by utilizing the TRAP (tartrate-resistant acid phosphatase) method. (Z)-Plicatin B (44), 
citrusin C (39), daidzein-4′-O-β-D-glucopyranoside (22) and liriodendrin (34) suppressed osteoclast 
formation with TRAP values of 86.05%, 100.93%, 104.77% and 106.05% of the control, respectively, at 
a concentration of 10 µM, considering that daidzein as the positive control had an inhibition of 131% 
at the same concentration [54]. 
3.8. Antioxidant Activities 
The free radicals scavenging potentials of the EOs from the flowers and fruits of D. assadii have 
been evaluated using the DPPH (2,2-diphenyl-1-picrylhydrazyl) assay. The activities were almost 
similar, the highest activities being recorded at 320 µL/mL EO from flowers and fruits, with 68% and 
69% inhibitions, respectively [26]. 
So far, only methanolic and ethanolic extracts of D. anethifolia have been analyzed for antiradical 
activity. In a study, the hydro-methanolic extract (80%) of the aerial parts exhibited antiradical 
activity with an IC50 value of 0.38 g/L and an EC50 of 0.63 g/L, in the DPPH and FRAP (ferric reducing 
antioxidant of potency) assays, respectively, while ascorbic acid and quercetin as positive controls 
showed higher activities in both assays (IC50 of 0.033 and 0.017 g/L in DPPH, and EC50 of 0.091 and 
0.026 g/L in FRAP, respectively) [49]. 
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The antioxidant capacity of the hydro-methanolic extract (80%) of D. anethifolia was measured 
by applying several methods. Overall, the plant sample revealed a more potent antioxidant activity 
compared to the controls. It is noteworthy that, in the DPPH and FRAP assays, the IC50 values of the 
extract were calculated as 15.22 and 17.02 µg/mL, respectively, while the standards BHT (butylated 
hydroxytoluene) and ascorbic acid were less active, with IC50 values of 17.29 and 58.91 µg/mL, and 
16.25 and 68.76 µg/mL, respectively [67]. In a similar work, DPPH results demonstrated the higher 
activity of the ethanolic extract of D. anethifolia leaf, with an IC50 of 122.02 ppm, compared to the ethyl 
acetate fraction (IC50: 354.37 ppm); however, both were less potent than BHT (IC50 45.64 ppm) [15]. 
ORAC (oxygen radical absorbance capacity) and CUPRAC (copper reducing capacity) assays 
were used to analyze the radical-scavenging potentials of the isolated constituents of D. ismaelis at 
two concentrations (1 and 10 µM). The most active radical scavengers were genistin (21), at 10 µM 
with 27 µM Trolox equivalent (TE) in the ORAC assay, and 4′-hydroxy-3,3′,4,5,5′-pentamethoxy-
7,9′:7′,9-diepoxylignane (33) at 24 µM TE in the CUPRAC assay [54]. 
The total antioxidant capacity of the EO from aerial parts of D. ismaelis was investigated by β-
carotene bleaching assay. In comparison to rutin (positive control), whose capacity was 91.2%, the 
EO indicated a 68.5% capacity in the same concentration of 1 mg/mL. The highest inhibition of the 
EO was also seen for 1 mg/mL, at 72.1%, whilst ascorbic acid had a 94.2% inhibition, evaluated by 
DPPH method [42]. 
3.9. Antiproliferative and Cytotoxic Activities 
Eight linear furanocoumarins isolated from D. anethifolia were analyzed to assess their 
antiproliferative and cytotoxic effects in vitro on PAR (L5178Y PAR mouse T-cell lymphoma), MDR 
(L5178Y human ABCB1-transfected subline) and NIH/3T3 (mouse embryonic fibroblast) cell lines. 
Among all the compounds, oxypeucedanin (3) and heraclenin (9) had the highest activities against 
the cancer cell lines. Oxypeucedanin (3) possessed the highest antiproliferative effect on the PAR and 
MDR cells, with ED50 (the drug dose producing 50% of a maximal effect) values of 25.98 and 28.89 
µM, however doxorubicin was more potent as the positive control, with ED50 0.054 and 0.46 µM, 
respectively. The most cytotoxic compound against PAR and MDR cells was also oxypeucedanin (3), 
with ED50 40.33 and 66.68 µM, although doxorubicin possessed greater activity, with ED50 values of 
0.37 and 7.15 µM, respectively. Assessment via checkerboard combination assay revealed that 
oxypeucedanin (3) (ratio of 1:50) and heraclenin (9) (ratio of 4:100) had a slight synergistic effect with 
doxorubicin, with ED50 values of 0.85 and 0.88 µM, respectively [2]. 
The in vitro cytotoxic potential of secondary metabolites isolated from the dichloromethane 
extract of D. anethifolia seeds was analyzed by applying an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay, which is a colorimetric method for evaluating cell metabolic 
activity. Ducrosin B (28) possessed the highest potential against human colon HCT-116 and ovarian 
carcinoma SKOV-3 cells, with IC50 41.0 and 54.0 µM, respectively, however those activities were lower 
than the anticancer drug tamoxifen, used as a positive control, with IC50 values of 1.0 and 1.4 µM, 
respectively [50]. 
EOs from Iranian D. anethifolia and D. flabellifolia were analyzed to assess cytotoxic activity via 
MTT assay on three cell lines, namely K562 (human chronic myelogenous leukemia), LS180 (human 
colon adenocarcinoma) and MCF-7 (human breast adenocarcinoma). Generally, the EO from D. 
anethifolia was more potent compared to D. flabellifolia, while the highest cytotoxicity was measured 
for the EO of D. anethifolia on the K562 cell line (IC50: 85.5 µg/mL); however, it was weaker than 
cisplatin as the positive control (IC50: 6.9 µg/mL) [8]. 
Another study evaluated the antiproliferative activities of three different extracts (ethanolic, 
chloroform and aqueous) of D. flabellifolia on three cell lines, HEp-2 (larynx carcinoma), MCF-7 and 
Vero (African green monkey kidney), using an MTT assay. Among the extracts, the hydro-ethanolic 
(95%) was the most active on all the tested cells. This extract exhibited a higher inhibitory capacity 
on Vero cell proliferation, with an IC50 of 87.50 µg/mL, compared to vincristine sulphate (IC50 > 90 
µg/mL) [61]. 
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The EO obtained from aerial parts of D. ismaelis showed cytotoxicity against the MCF-7 cell line, 
characterized by an IC50 value of 66.24 µg/mL, although vinblastine was more potent (1.8 µg/mL). On 
the HEpG2 (liver cancer) and LoVo (colon cancer) cell lines, weaker activities were observed [42]. 
3.10. Neuroprotective Activities 
In an animal experiment using a Morris water maze test, the impact of EO from D. anethifolia’s 
aerial parts on spatial learning and memory in rats was evaluated. The EO at a dose of 0.5 mL/kg 
remarkably increased the escape latency after the 2nd, 3rd and 4th treatments. Furthermore, the latency 
to find the hidden platform was significantly reduced on all the days of treatment (at 0.25 mL/kg), 
except the first day. Besides, compared to the control group, the time needed and the distance 
travelled to the target zone were both increased after administering 0.5 mL/kg EO. In conclusion, the 
EO of D. anethifolia, at doses of 0.25 and 0.5 mL/kg after four days of treatment, demonstrated a good 
capacity for improving spatial learning and memory in rats [68], thus more clinical trials are required 
to further prove its efficacy. 
3.11. Other Pharmacological Activities 
In an in vivo study, the effect of D. anethifolia EO on the blood immune parameters of rainbow 
trout (Oncorhynchus mykiss) was investigated. No impacts on serum bactericidal, serum lysozyme or 
respiratory burst activities were observed [69]. 
The enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) inducer activity of the methanolic 
extract of D. anethifolia (80%), gained from the aerial parts, was assessed against murine hepatoma 
(Hepa1c1c7) cells. In comparison to sulforaphane as the positive control, the extract demonstrated a 
higher effect, with CD (concentration that doubles the specific activity of NQO1) values of 35.45 
µg/mL vs. of 32 µg/mL, and a maximum induction of 4.5-fold vs. 2.5-fold [70]. 
The influence on testosterone concentration of a hydro-ethanolic extract (80%) from D. 
anethifola’s aerial parts was assessed on Wistar rats using a radioimmunoassay. The plant extract 
significantly decreased testosterone levels (0.24 ng/mL in animals treated with 140 mg/kg extract, 
compared to 2.4 ng/mL in the control group) [71]. 
The hypolipidemic activity of EOs obtained from the leaf and stem of D. anethifolia was 
investigated on streptozotocin-induced diabetic rats. The results of the group treated with EO were 
comparable to those of the control groups treated with glibenclamide. The total cholesterol of the EO 
group was 87.0 ug/dL, while in the control group treated with glibenclamide, it was 84.69 ug/dL. 
Moreover, the triglyceride levels of the EO-treated group and the glibenclamide control group were 
39.40 and 38.18 ug/dL, respectively. In the EO group, HDL (high-density lipoprotein) and LDL (low-
density lipoprotein) cholesterol were 18.23 mg/dL and 39.96 ug/dL, respectively, whereas in the 
glibenclamide group, similar results were recorded (18.82 mg/dL and 38.23 ug/dL, respectively) [48]. 
4. Conclusions and Prospective 
The Ducrosia genus includes six species, mainly growing in Asia, particularly Iran, Saudi Arabia, 
Afghanistan, Pakistan and Iraq. D. anethifolia, as the most common species, has been traditionally 
consumed as a remedy for anxiety and insomnia, and as analgesic in Iranian folk medicine. It should 
be noted that the herbs of this species have been used as food additives in cuisine. Further species of 
the Ducrosia genus (e.g., D. flabellifolia and D. assadii) have also been known for their use as anti-
inflammatory, antiseptic, carminative and soporific agents in traditional medicine. 
Two species, D. anethifolia and D. ismaelis, have been analyzed to isolate their non-volatile 
secondary metabolites. A total of 17 linear furanocoumarins, 8 flavonoids, 5 terpenoids, 3 
phytosterols and 2 alkaloids have been identified as the major compounds of these Ducrosia species. 
Furanocoumarins, as the main constituents of the genus, were present at the highest concentrations 
in the chloroform extracts of the aerial parts, however their occurrence in different plant parts has 
not been comprehensively studied. In general, among all the isolated compounds, four constituents, 
including one dihydrochalcone glycoside ismaeloside A (25), one pterocarpan glycoside glycinol-3-
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O-β-D-glucopyranoside (41), a monoterpene ducrosin A (26) and one sesquiterpene ducrosin B (28), 
have been characterized as the novel secondary metabolites. 
The plants of this genus contain remarkable amounts of volatile compounds, predominantly 
analyzed in the fresh aerial parts of D. anethifolia, but different plant parts of D. assadii, D. flabellifolia 
and D. ismaelis have also been tested for their essential oil composition. Overall, decanal and 
dodecanal (aldehyde hydrocarbons), cis-chrysanthenyl acetate and α-pinene (monoterpene 
hydrocarbon) have been identified as the major fragrant compounds of the Ducrosia genus. 
Except for one clinical trial, all the pharmacological investigations into the Ducrosia genus have 
been carried out in vivo (analgesic, antidiabetic, antianxiety, etc.) or in vitro (e.g., antimicrobial, 
antioxidant, antiproliferative), specifically on D. anethifolia as the most renowned and available plant 
species. 
The efficacy and safety of the plants have not been investigated yet in detail. Further experiments 
are necessary to support the rationale of the folk medicinal applications, and the safety, of Ducrosia 
species. 
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